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Interleukins 33 and 1B serum levels and common carotid arteries
remodeling in hypertensive patients with obesity
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Kharkiv National Medical University, Propedeutics To Internal Medicine
No.1, Kharkiv, Ukraine
Objective: To investigate interrelations between interleukin 33 (IL-33) and
1β (IL-1β) serum levels and common carotid arteries (CCA) remodeling in
hypertensive patients with obesity.
Method: 80 hypertensive patients (51 obese) have been observed. An
ultrasound examination of CCA with estimation of its geometrical type was
performed (cut-off value for vascular wall hypertrophy was vascular segment
mass >0,275 g/cm, concentric remodeling was diagnosed with relative wall
thickness of CCA >0,2). IL-33 and IL-1B serum levels were estimated using
ELISA.
Results: IL-33 and IL-1β levels were higher in hypertensive patients
(p<0,001), independently of BMI. Cluster analysis was made to reveal both
cytokines' levels impact on CCA geometry (see picture). IL-33≥73 pg/ml, IL-
1β≥25 pg/ml was associated with 80,0% prevalence of normal CCA geometry
and 20,0% of its concentric hypertrophy. IL-1β≥20 pg/ml with IL-33<71 pg/ml
was characterized by 80,0% prevalence of normal geometry, 10,0% of non-
hypertensive concentric remodeling of CCA, 5,0% of concnetric and 5,0% of
eccentric hypertrophy. IL-33≥71 pg/ml with IL-1β<25 pg/ml was associated
with decrease of normal CCA geometry prevalence to 50,0% with increase of
concentric hypertrophy rate to 41,7%; other 8,3% patients had eccentric
hypertrophy of CCA. IL-33<71 pg/ml, IL-1β<20 pg/ml (p>0,05 vs control
group) had 57,9% of normal geometry, 15,8% of concentric remodeling,
15,8% of concnetric hypertrophy and 10,5% of eccentric hypertrophy of CCA.
Conclusion: IL-33 and IL-1β serum levels were elevated in hypertensive
patients independently of presence of obesity. A pronounced isolated increase
in IL-33 level was associated with abrupt increase of CCA hypertrophy prev-
alence, especially its concentric variant. Accompanying increase in IL-1B
level reduced this effect. 
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Abdominal aortic aneurysms repair by entirely percutaneous endo-
vascular approach using closure suture-based device. Prospective
study of safety, feasibility and efficiency
Redouane Saady (1), Antoine Sauguet (2), Denis Doyen (1), Emile Ferrari (1),
Jean Fajadet (2)
(1) CHU Nice, Cardiologie, Nice, France – (2) Clinique Pasteur, Cardio-
logie, Toulouse, France
Background: Endovascular repair of abdominal aortic anevrysms (AAA)
is a well documented option. This approach is usually performed by surgical
cut down of the common femoral arteries (CFA). Total percutaneous access
for endovascular aortic anevrysm repair (« preclose technique ») has been
reported. However high bleeding risk obese patients are still considered as bad
candidates for this method. 
Aims: We describe our experience of the entirely percutaneous vascular
approach using the Prostar XL system, in our obese population in particular. 
Methods: We analyzed 164 consecutive patients treated for AAA by endo-
vascular percutaneous route between January 2007 and February 2012. Mean
age of our patients was 76 years old. 25.8%of our population were obese
(mean body mass index = 36). All patients were treated with a bifurcated
endoprosthesis. The diameter of the introducer was 18-French (F) for the main
femoral access and 12F for the controlateral access. The success rate of the
procedure has been described elsewhere. A total of non-surgical 328 femoral
access sites were closed with the Prostar XL system. 
Results: The success rate of the entirely percutaneous vascular approach
procedure was 94,5% and reached 100% in obese population, with a mean
delay to hospital discharge of 6 days. Nine procedure failures were deplored.
All procedure failures occurred on the 18F side while the success rate was
100% with 12F introducers (p=0.002). Re-hospitalization rate due to vascular
access complication (haematoma, false anevrysm, femoral abscess) was 2.4%
after a mean follow-up of 23 months, but no difference between obese and
non-obese patients was found. 
Conclusion: Our results indicate that even in obese patients, usually con-
sidered as relatively contra-indicated to this strategy, the entirely percutaneous
approach using the Prostar device for endovascular treatment of infrarenal
AAA is safe.
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Analysis of blood pressure variability in the systolic hypertension with
telemonitoring: feasibility and results on 108 patients
Patrick Dary
Cabinet de Cardiologie, Saint Yrieix La Perche, France
Purpose: Blood pressure (BP) and its variability (BPV) are associated with
an increased risk for cardiovascular mortality. This observational study
explores the benefits of patients telemonitoring using self-measured BP to
optimise treatment and its usefulness in the variability analysis
Methods: Patients with uncontrolled hypertension were enrolled during an
appointment. 2 SMBP were taken in the morning, at midday and in the eve-
ning at set times, the results being sent to a secure server. After 5 days treat-
ment was started if the mean reading was more than 140/90. Variability
analysis has been realized during all the follow up. The evaluation made at the
end of the first 5 days to obtain the mean, standart Deviation (SD), coefficient
of variation (CV), hight and low BP
Results: 63 women and 45 men. BP = 176/96 at inclusion dropping to 160/
88 after 5 days under the same treatment. Therapeutic adjustments achieved
over 12.7 days with significant decrease in BP to 143/82: –17 systolic and –6
diastolic (p<0.0001)
Results of variability are SD=16.63±5 and CV=0.105±0.03. There is no
difference according age (<70 years CV 0.104/>70 years CV 0.106, p=0.582)
or the level of BP (BP< 160 mmhg CV 0.109/ BP> 160mm hg CV 0.100; p
= 0.100). At first variability is of 0.105 (32 measures, 4.7 days) with a not sig-
nificant increase at the end: 0.112 (52 measures; p=0.098)
When variability >0.10, the risk of low BP increases (104/118, p<0.0001; CV
=0.136/0.087, p<0.0001), for the same mean BP(146/142, p=0.152), number of
treatment (2.71/2.86, p=0.443) and for the same age (69,8/66,8, p=0.152) SBP of
all measures is lowest at midday: 164mm hg morning, 153mm hg midday
(–11mm, p<0.0001), 163mm hg evening with the same difference at the end of
follow up (147/138). The gap increases >74 years (–14mm de hg; 170/156)
Conclusions: Awareness of the variance between average clinic and
average telemonitoring BP may influence the diagnostic and management of
hypertension.Telemonitoring of BP allows the real time measure of the mean,
SD, CV and hight and low BP after modification or new treatment.The real
time analysis allows the control of hypertension to improve (figure next page). 
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Plasma interleukin-18 levels depend on hypertriglyceridemic waist
phenotype and gender in patients with arterial hypertension
Tetyana Ashcheulova, Ime Ime Etukudo, Olga Kovalyova, Abdel Nur
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Ukraine
The aim our study was to investigate cardiometabolic risk factors and
plasma interleukin-18 (IL-18) levels in relationships with hypertriglyceridemic
waist phenotype (HTGW) depend on gender of patients with arterial hyper-
tension (AH). 
Methods: Anthropometric parameters, carbohydrate and lipid metabolism,
circulating IL-18 levels in 101 patients with AH (men (n=45; 44.6%) and
women (n=56; 55.4 %) aged 32-80 years) were examined. HTGW was defined
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